Supporting Australians with Cystic Fibrosis

From April 1, Trikafta® will be available on the PBS for Australians with Cystic Fibrosis aged 12 years and older who meet the criteria.
Cystic fibrosis is a progressive, genetic disease that causes persistent lung infections and the median life expectancy for Australians with Cystic Fibrosis is 47 years.
This is a landmark listing for Aussies with CF and their families which will support nearly 1900 patients, who without subsidy would pay around $250,000 a year for treatment. Instead, from April 1, they’ll pay $42.50 per script, or as little as $6.80 with a concession card.
Since 2013, our Government has approved more than 2,800 new and amended listings on the PBS at an overall investment of $15 billion.
For more information and details on the criteria click HERE.